END-OF-YEAR SALE | 30% off all products while supplies last | Use code: CLICK30%

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
product_variation

END-OF-YEAR SALE | 30% off all products while supplies last | Use code: CLICK30%

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
product_variation

Latest News

  • 24
    Jun

    Novartis Acquires Regulus Therapeutics to Advance microRNA-Based Therapy for ADPKD

    Novartis has announced its acquisition of Regulus Therapeutics in a transaction valued at up to $1.7 billion. This strategic move aims to advance farabursen, an

    MORE →

  • 6
    Jun

    baseclick GmbH secures revolutionary U.S. Patent for Click modified mRNA Technology

    Development of innovative platform enhances mRNA therapeutics with improved stability, targeting and delivery Neuried, Germany (June 06, 2025) baseclick GmbH, a leader in nucleic acid

    MORE →
  • scheme for DNA-ClickSeq Kit

    20
    May

    New Product Launch: DNA-ClickSeq Library Prep Kit

    baseclick GmbH and ClickSeq Technologies are excited to announce the launch of our DNA-ClickSeq Library Prep Kit. This new product expands our portfolio of innovative

    MORE →

  • 30
    Apr

    baseclick and ZAGENO Announce Strategic Partnership to Enhance Lab Supply Procurement for Pharma, Biotech and research laboratories

    Neuried, Germany (April 30, 2025) baseclick GmbH, a leading innovator in nucleic acid-based drug and therapeutic development, and ZAGENO, one of the world’s largest marketplaces

    MORE →
  • oligonucleotide drug development

    21
    Feb

    Take your oligonucleotide from concept to preclinical with baseclick

    At baseclick we specialise in guiding you through every stage of oligonucleotide drug development. We ensure efficiency, precision and regulatory compliance. Our expertise covers: Oligo

    MORE →